Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI (LP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Juan A Garcia-Velasco, IVI Madrid
ClinicalTrials.gov Identifier:
NCT00780858
First received: October 25, 2008
Last updated: May 5, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)